A detailed history of Allworth Financial LP transactions in Novartis Ag stock. As of the latest transaction made, Allworth Financial LP holds 3,902 shares of NVS stock, worth $384,151. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,902
Previous 3,816 2.25%
Holding current value
$384,151
Previous $406,000 10.34%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$106.13 - $120.89 $9,127 - $10,396
86 Added 2.25%
3,902 $448,000
Q2 2024

Jul 23, 2024

BUY
$92.57 - $107.37 $7,961 - $9,233
86 Added 2.31%
3,816 $406,000
Q1 2024

Apr 25, 2024

SELL
$95.27 - $108.47 $4,763 - $5,423
-50 Reduced 1.32%
3,730 $360,000
Q4 2023

Jan 24, 2024

BUY
$92.27 - $101.54 $67,633 - $74,428
733 Added 24.06%
3,780 $381,000
Q3 2023

Oct 31, 2023

SELL
$94.73 - $105.13 $16,861 - $18,713
-178 Reduced 5.52%
3,047 $310,000
Q2 2023

Jul 18, 2023

SELL
$92.52 - $104.91 $1,572 - $1,783
-17 Reduced 0.52%
3,225 $325,000
Q1 2023

Apr 18, 2023

BUY
$80.03 - $92.81 $9,123 - $10,580
114 Added 3.64%
3,242 $298,000
Q4 2022

Jan 13, 2023

SELL
$75.55 - $92.52 $7,026 - $8,604
-93 Reduced 2.89%
3,128 $0
Q3 2022

Oct 18, 2022

BUY
$74.61 - $87.26 $76,400 - $89,354
1,024 Added 46.61%
3,221 $245,000
Q2 2022

Jul 13, 2022

BUY
$80.52 - $93.75 $15,459 - $18,000
192 Added 9.58%
2,197 $186,000
Q1 2022

Apr 22, 2022

SELL
$80.11 - $90.62 $3,204 - $3,624
-40 Reduced 1.96%
2,005 $176,000
Q4 2021

Jan 21, 2022

BUY
$79.7 - $88.13 $48,537 - $53,671
609 Added 42.41%
2,045 $179,000
Q3 2021

Nov 02, 2021

BUY
$81.78 - $95.14 $84,478 - $98,279
1,033 Added 256.33%
1,436 $117,000
Q2 2021

Aug 02, 2021

BUY
$85.24 - $94.15 $14,831 - $16,382
174 Added 75.98%
403 $37,000
Q1 2021

Apr 29, 2021

SELL
$83.5 - $98.47 $4,759 - $5,612
-57 Reduced 19.93%
229 $20,000
Q4 2020

Jan 26, 2021

SELL
$78.07 - $94.43 $19,517 - $23,607
-250 Reduced 46.64%
286 $27,000
Q3 2020

Nov 03, 2020

SELL
$82.14 - $91.0 $6,406 - $7,098
-78 Reduced 12.7%
536 $47,000
Q2 2020

Jul 24, 2020

BUY
$80.93 - $91.1 $4,046 - $4,555
50 Added 8.87%
614 $54,000
Q1 2020

Apr 17, 2020

BUY
$70.67 - $99.01 $3,604 - $5,049
51 Added 9.94%
564 $46,000
Q4 2019

Jan 16, 2020

SELL
$84.35 - $95.37 $28,341 - $32,044
-336 Reduced 39.58%
513 $49,000
Q2 2019

Jul 25, 2019

SELL
$75.4 - $92.8 $7,690 - $9,465
-102 Reduced 10.73%
849 $78,000
Q1 2019

May 07, 2019

BUY
$75.32 - $86.15 $46,171 - $52,809
613 Added 181.36%
951 $91,000
Q4 2018

Feb 11, 2019

BUY
$73.66 - $82.02 $7,366 - $8,202
100 Added 42.02%
338 $29,000
Q2 2018

Aug 08, 2018

BUY
$64.91 - $73.36 $259 - $293
4 Added 1.71%
238 $18,000
Q4 2017

Feb 22, 2018

SELL
$72.33 - $77.64 $9,547 - $10,248
-132 Reduced 36.07%
234 $20,000
Q3 2017

Oct 12, 2017

BUY
$74.14 - $77.27 $6,746 - $7,031
91 Added 33.09%
366 $31,000
Q2 2017

Aug 07, 2017

BUY
N/A
275
275 $23,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.